Myopic macular degeneration (MMD) is a serious eye condition that can cause vision loss that gets worse over time. Treatment may help reduce complications of MMD. Myopic macular degeneration (MMD ...

Three studies showed that adults aged 20 to 50 years with myopia experienced about –1 D of progression. Most progression occurred between 20 and 30 years of age. Perspective from Alexander ...

Langis Michaud has received research funding from Bausch and Lomb, Neurolens and Fitlens. He has received speaker's fees from Johnson and Johnson and Essilor. Université de Montréal provides ...

Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This proportion is increasing so quickly that it ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...

Aims To determine if ‘Defocus Incorporated Soft Contact’ (DISC) lens wear slows childhood myopia progression. Methods A 2-year double-blind randomised controlled trial was carried out in 221 children ...

If approved, SYD-101 would be the first pharmaceutical treatment to slow the progression of pediatric myopia in the U.S. The FDA accepted a new drug application for SYD-101 to slow the progression ...